M
Melina Farshbafnadi
Researcher at Tehran University of Medical Sciences
Publications - 5
Citations - 63
Melina Farshbafnadi is an academic researcher from Tehran University of Medical Sciences. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 3 publications receiving 7 citations.
Papers
More filters
Journal ArticleDOI
Aging & COVID-19 susceptibility, disease severity, and clinical outcomes: The role of entangled risk factors.
Melina Farshbafnadi,Sara Kamali Zonouzi,Sara Kamali Zonouzi,Mohammadmahdi Sabahi,Mahsa Dolatshahi,Mahsa Dolatshahi,Mohammad Hadi Aarabi +6 more
TL;DR: A plethora of mechanisms and risk factors contribute to the higher risk of infection in the old population as discussed by the authors, including aging associated with an increment in the expression of Angiotensin-Converting Enzyme-2 (ACE-2), the receptor for SARS-CoV-2 spike protein.
Journal ArticleDOI
The second brain: The connection between gut microbiota composition and multiple sclerosis
TL;DR: In this article, the authors examined the possible link between gut microbiota composition and multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE), and found that patients with MS suffer from dysbiosis.
Journal ArticleDOI
Immune checkpoint inhibitors for triple-negative breast cancer: From immunological mechanisms to clinical evidence
TL;DR: In this paper, the authors provide information on the mechanisms of action of ICIs, review the efficacy results of clinical trials using ICIs for TNBC treatment, and assess the side effects of such drugs.
Journal ArticleDOI
Post-discharge Thromboembolic Events in COVID-19 Patients: A Review on the Necessity for Prophylaxis
TL;DR: In this paper , the authors reviewed and summarized available literature upon incidence, prevention, diagnosis, and therapeutic approaches for venous thromboembolism (VTE) in COVID-19 patients.
Journal ArticleDOI
Nanoimmunoengineering strategies in cancer diagnosis and therapy
Robabehbeygom Ghafelehbashi,Melina Farshbafnadi,Niloofar Shokraneh Aghdam,Shahin Amiri,Mitra Salehi,Sepideh Razi +5 more
TL;DR: Improved approaches connected to the efficacy of nanoimmunoengineering strategies for cancer immunotherapies and their applications are assessed by assessing improved approaches.